Survival benefits of second-line chemotherapy in metastatic castrate-resistant prostate cancer (CRPC) in a southeastern oncology community practice.
James W. Gilmore
No relevant relationships to disclose
Sally Haislip
No relevant relationships to disclose
Stephen Szabo
Employment or Leadership Position - Georgia Cancer Specialists
Consultant or Advisory Role - Amgen
Sean D Sullivan
Consultant or Advisory Role - Bayer
Scott David Ramsey
Consultant or Advisory Role - Bayer
Charles Kreilick
Employment or Leadership Position - Bayer
Susan H Foltz Boklage
Employment or Leadership Position - Bayer
Syam Sarma
Consultant or Advisory Role - Bayer
Carl V Asche
Consultant or Advisory Role - Bayer
Kenneth M. Shermock
Consultant or Advisory Role - Bayer
Kai Sun
No relevant relationships to disclose
Satish Valluri
Employment or Leadership Position - Bayer
Brian S. Seal
Employment or Leadership Position - Bayer
Stock Ownership - Bayer